DUOX2 and cyclic hematopoiesis: Although there is no information from the published literature that any of the previously reported CH patients with DUOX2 mutations had GI symptoms, anecdotal support for the potential role of DUOX2 in IBD pathogenesis has been recently provided by reports of DUOX2 loss-of-function mutations in children with IBD but not CH13–15.